How many 100 units/mL insulin degludec (Tresiba) pens are needed for a patient who takes 80 units twice daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 7, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tresiba 100 units/mL Pen Supply Calculation

For a patient taking 80 units twice daily (160 units/day total), you will need approximately 9 pens per month.

Calculation Breakdown

Daily insulin requirement:

  • 80 units × 2 doses = 160 units per day

Monthly insulin requirement:

  • 160 units/day × 30 days = 4,800 units per month

Tresiba U-100 FlexTouch pen specifications:

  • Each pen contains 300 units total 1
  • Maximum dose per injection: 80 units
  • Dose increment: 1 unit

Number of pens needed:

  • 4,800 units ÷ 300 units per pen = 16 pens per month

However, there is a critical dosing issue to address:

Important Clinical Consideration

Insulin degludec (Tresiba) is a long-acting basal insulin designed for once-daily dosing, not twice-daily administration 1. The pharmacokinetic profile of degludec provides ultra-long duration of action exceeding 42 hours with a flat, stable glucose-lowering effect 2.

Recommended Dosing Adjustment

  • The patient should be transitioned to once-daily dosing rather than twice-daily
  • If the patient requires 160 units total daily, this should be given as a single 160-unit injection once daily
  • This would require the U-200 FlexTouch pen instead, which can deliver up to 160 units in a single injection 1

If Using U-200 Pens (Recommended)

U-200 FlexTouch pen specifications:

  • Each pen contains 600 units total 1
  • Maximum dose per injection: 160 units (perfect for this patient)
  • Dose increment: 2 units

Monthly requirement with once-daily dosing:

  • 160 units/day × 30 days = 4,800 units per month
  • 4,800 units ÷ 600 units per pen = 8 pens per month

If Continuing Twice-Daily Dosing with U-100 Pens

If the prescriber insists on maintaining twice-daily dosing (which is not standard practice for degludec):

  • 16 pens per month as calculated above
  • Each pen lasts approximately 1.9 days at this dosing regimen

Clinical Pitfall Warning

Do not use a syringe to withdraw insulin from the FlexTouch pen 1. The pen is designed as a single-patient-use device with built-in dose accuracy. Using a syringe to withdraw insulin from the pen cartridge can lead to serious dosing errors and contamination.

References

Related Questions

For a patient prescribed insulin degludec (Tresiba FlexTouch) 100 U/mL pen to inject 25 units subcutaneously in the morning and 25 units in the evening for a 90‑day supply with no refills, how many pens are needed?
A patient on insulin degludec 8 units, NPH 28 units, and a carbohydrate‑to‑insulin ratio of 1 unit per 6 g has blood glucose values of 134 mg/dL at 8 am, 177 mg/dL at noon, 198 mg/dL at 5 pm, 270 mg/dL at 9 pm, and 100 mg/dL at 2 am. If the degludec dose will be reduced to 6 units today, what should the NPH dose be and what carbohydrate‑to‑insulin ratio should be used?
What alternative long‑acting basal insulin can replace the discontinued insulin degludec FlexPen (Tresiba FlexTouch)?
Can a patient increase Tresiba (insulin degludec) by 2 units if blood glucose levels are elevated for 3-4 days?
What is the appropriate discharge regimen for a patient receiving a high daily dose of intravenous insulin, transitioning to pre‑meal rapid‑acting insulin boluses, basal insulin glargine, and oral hypoglycemic agents?
What are the size thresholds for surgical repair of thoracic aortic aneurysms, including the ascending aorta/root, descending thoracic aorta, and earlier intervention criteria for connective‑tissue disease, bicuspid aortic valve, or strong family history of dissection?
What is the appropriate management for recurrent parietal headaches?
What are the complete causes of achalasia?
What are the differences between cellulitis, osteomyelitis, and necrotizing fasciitis?
What is the differential diagnosis for a patient with macrocytic anemia (hemoglobin 9.8 g/dL, hematocrit 31.5 %, mean corpuscular volume 105 fL, mean corpuscular hemoglobin concentration 31 g/dL, red cell distribution width 23.7 %) and a neutrophil predominance (neutrophils 84.8 %, lymphocytes 10.3 %)?
What is the appropriate evaluation and management for an 18‑month‑old child who, after seizures have been excluded, wakes at night screaming and demanding leg rubbing?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question